Turing Pharma

'Turing Pharma' - 3 News Result(s)

  • 'Most Hated Man' Gets Seven Years In Jail For Defrauding Investors
    World News | Agence France-Presse | Saturday March 10, 2018
    Infamous "Pharma Bro" Martin Shkreli, once dubbed the most hated man in America for ratcheting up the price of an HIV drug, was sentenced to seven years prison Friday on charges of defrauding investors.
    www.ndtv.com
  • Turing Pharma Names Chairman To Replace Martin Shkreli As CEO
    World News | Reuters | Saturday December 19, 2015
    Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday.
    www.ndtv.com
  • Martin Shkreli, the Bad Boy of Pharmaceuticals, Hits Back
    Business | Andrew Pollack and Julie Creswell, The New York Times | Monday December 7, 2015
    A former hedge fund manager, Shkreli drew the wrath of consumers, became a talking point in the presidential campaign and spurred federal and state inquiries as well as a dialogue about how and whether to control rising drug prices.
    www.ndtv.com/business

'Turing Pharma' - 3 News Result(s)

  • 'Most Hated Man' Gets Seven Years In Jail For Defrauding Investors
    World News | Agence France-Presse | Saturday March 10, 2018
    Infamous "Pharma Bro" Martin Shkreli, once dubbed the most hated man in America for ratcheting up the price of an HIV drug, was sentenced to seven years prison Friday on charges of defrauding investors.
    www.ndtv.com
  • Turing Pharma Names Chairman To Replace Martin Shkreli As CEO
    World News | Reuters | Saturday December 19, 2015
    Martin Shkreli, the poster boy for prescription drug price increases who was arrested for securities fraud this week, has stepped down from his post as chief executive officer of Turing Pharmaceuticals Inc, the company said on Friday.
    www.ndtv.com
  • Martin Shkreli, the Bad Boy of Pharmaceuticals, Hits Back
    Business | Andrew Pollack and Julie Creswell, The New York Times | Monday December 7, 2015
    A former hedge fund manager, Shkreli drew the wrath of consumers, became a talking point in the presidential campaign and spurred federal and state inquiries as well as a dialogue about how and whether to control rising drug prices.
    www.ndtv.com/business
Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com
Listen to the latest songs, only on JioSaavn.com